Viewing Study NCT05378867


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-27 @ 9:58 AM
Study NCT ID: NCT05378867
Status: UNKNOWN
Last Update Posted: 2022-05-18
First Post: 2022-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC
Sponsor: Zhejiang Teruisi Pharmaceutical Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module